Business Wire

ISLAMIC-DEVELOPMENT-BANK

13.5.2023 11:26:30 CEST | Business Wire | Press release

Share
Global Partnerships and Sustainable Financing Top Agenda at IsDB Group 2023 Annual Meetings in Jeddah

Policymakers and business leaders from around the world are deliberating over how to tackle obstacles to sustainable development during the Islamic Development Bank (IsDB) Group’s Annual Meetings underway in Jeddah, Kingdom of Saudi Arabia.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230513005002/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Islamic Development Bank (IsDB) President and Group Chairman, H.E. Dr. Muhammad Al Jasser (Photo: AETOSWire)

Held under the theme, “Partnerships to Fend off Crises,” the 48th edition of the annual meetings has brought together high-ranking government officials and senior business executives to discuss a range of topics such as poverty alleviation, healthcare, education, women and youth empowerment, food security, and climate change.

The four-day event includes both high-level plenary sessions and technical symposiums, to identify effective solutions for economic and development issues faced by the IsDB Group’s 57 member countries (MCs) and its partners.

On the opening day on Wednesday, the IsDB Group Boards Meeting approved financing valued at more than US$558 million for six projects in member countries. The projects focus on supporting inclusive growth and infrastructure development in line with the Sustainable Development Goals (SDGs). The day also witnessed the launch of the ‘IsDB Group Integration Report for Arab Region,’ which measures the progress of economic integration within the Arab region and provides a framework to strengthen trade between the Bank’s MCs.

While the side events of this major event are well underway from 10 May, the official opening ceremony of the event was held on Thursday. Delivering the keynote address, H.E. Dr. Muhammad Al Jasser, President and Group Chairman of IsDB, reaffirmed the Bank Group’s commitment to promoting resilience and providing financing within MCs to help overcome challenges in the backdrop of shifting monetary conditions.

“To support its member countries in tackling crises, the IsDB Group has launched several ambitious initiatives, including a program to address the effects of the pandemic with an amount of USD 4.3 billion, which we have fully implemented, and the Food Security Response Program valued at more than USD 10 billion over the next three years, in addition to committing to contributing to climate finance with an amount of at least USD 13 billion until 2030.”

Meanwhile, the IsDB Group Private Sector Forum, which is taking place from 11-13 May on the sidelines of the annual meetings, is paving the way for stronger public-private partnerships that drive inclusive development and support innovative, sustainable financing.

*Source: AETOSWire

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230513005002/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release

- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur

Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release

Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i

Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release

Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up

Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release

Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different

Sutherland Launches FinAI Hub to Industrialize Agentic AI for Banking and Financial Services6.3.2026 14:00:00 CET | Press release

A domain-trained AI agent workforce enables production-scale AI across regulated financial institution operations Today, Sutherland announced the launch of Sutherland FinAI Hub, an enterprise Agentic AI platform built exclusively for Banking and Financial Services. As financial institutions accelerate AI adoption, many initiatives remain confined to pilots, unable to scale across legacy systems and core operations. Sutherland FinAI Hub is designed to help close that gap. FinAI Hub is an innovation ecosystem where Sutherland works with clients to design, prototype, and scale Agentic AI workflows across core operations. At launch, the platform brings together a large and expanding workforce of domain-trained AI agents purpose-built for financial institutions, supporting functions across retail banking, payments, cards, consumer and commercial lending, servicing, back office, risk and compliance functions. These modular agents can operate independently or be orchestrated across end-to-end

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye